drugset / Trial / NCT00004416

Randomized Study of Botulinum Toxin Type A for Achalasia

NCT00004416

Completed 56 enrolled University of Texas
Treatment

Summary

OBJECTIVES: I. Compare the efficacy of two doses of botulinum toxin in the treatment of achalasia. II. Compare the safety of these two doses in these patients.

Timeline

Start
1997-01
Primary completion
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic Other

Indications